Yıl: 2022 Cilt: 2 Sayı: 3 Sayfa Aralığı: 36 - 46 Metin Dili: İngilizce DOI: 10.14744/eer.2022.57966 İndeks Tarihi: 21-05-2023

Ocular syphilis

Öz:
Syphilis is a sexually transmitted systemic disease caused by the spirochete Treponema pallidum. If left untreated, syphilis progresses in four stages: Primary, secondary, latent, and tertiary. Since the turn of the 20th century, the global prevalence of syphilis has sharply increased. Syphilis and human immunodeficiency virus (HIV) coinfection are common because they share similar transmission routes. Ocular syphilis (OcS) is a rare syphilis complication, but its prevalence has recently in- creased as a result of the rise in syphilis cases. OcS may occur at any stage of syphilis. However, it may not always be accom- panied by systemic findings. In such cases, ocular involvement may be the disease’s first and only manifestation. OcS can affect any structure of the eye, yet the most common manifestations are posterior uveitis and panuveitis. Due to the variety of clinical manifestations, the disease is known as “the great imitator.” As a result, syphilis serology is advised for any patient with unknown intraocular inflammation. Although clinical signs can be indicative of OcS, it is diagnosed using laboratory tests. Multimodal ocular imaging is required for differential diagnosis, treatment, and follow-up. It is highly recommended that patients with suspected or confirmed syphilis be tested for HIV infection. OcS is treated just like neurosyphilis with systemic penicillin. If OcS is treated promptly and effectively, a good visual prognosis is possible; otherwise, it may lead to permanent blindness.
Anahtar Kelime: Diagnosis manifestations ocular syphilis syphilis serology treatment uveitis.

Belge Türü: Makale Makale Türü: Diğer Erişim Türü: Erişime Açık
  • Furtado JM, Simões M, Vasconcelos-Santos D, Oliver GF, Ty- agi M, Nascimento H, et al. Ocular syphilis. Surv Ophthalmol 2021;67:440–465.
  • Tsan GL, Claiborne RT. Ocular syphilis. Clin Exp Optom 2021;104:756–9.
  • Centers for Disease Control and Prevention. Sexually Transmitted Diseases (STDs): Clinical Advisory: Ocular Syphilis in the United States. Atlanta, Georgia: Centers for Disease Control and Prevention; 2016. Available from: https://www.cdc.gov/std/ syphilis/clinicaladvisoryos2015.htm. Accessed Aug 3, 2022.
  • Doris JP, Saha K, Jones NP, Sukthankar A. Ocular syphilis: The new epidemic. Eye (Lond) 2006;20:703–5.
  • Furtado JM, Arantes TE, Nascimento H, Santos DV, Nogueira N, Queiroz R, et al. Clinical manifestations and ophthalmic outcomes of ocular syphilis at a time of re-emergence of the systemic infection. Sci Rep 2018;8:12071.
  • Centers for Disease Control and Prevention. Sexually Transmitted Diseases (STDs): Surveillance Report. Atlan- ta, Georgia: Centers for Disease Control and Prevention; 2018. Available from: https://www.cdc.gov/nchhstp/news- room/2019/2018-STD-surveillance-report.html. Accessed Aug 3, 2022.
  • Mathew RG, Goh BT, Westcott MC. British ocular syphilis study (BOSS): 2-year national surveillance study of intraocular in- flammation secondary to ocular syphilis. Invest Ophthalmol Vis Sci 2014;55:5394–400.
  • Lee SY, Cheng V, Rodger D, Rao N. Clinical and laboratory char- acteristics of ocular syphilis: A new face in the era of HIV co-in- fection. J Ophthalmic Inflamm Infect 2015;5:56.
  • Oliver SE, Aubin M, Atwell L, Matthias J, Cope A, Mobley V, et al. Ocular syphilis-eight jurisdictions, United States, 2014- 2015. MMWR Morb Mortal Wkly Rep 2016;65:1185–8.
  • Eslami M, Noureddin G, Pakzad-Vaezi K, Warner S, Grennan T. Resurgence of ocular syphilis in British Columbia between 2013 and 2016: A retrospective chart review. Can J Ophthal- mol 2020;55:179–84.
  • Yaici R, Balasiu A, MacKenzie CR, Roth M, Beseoglu K, Holt- mann C, et al. Ocular Syphilis: Experience over 11 years at a German Ophthalmology Reference Centre. Ocul Immunol Inflamm 2021;19:1–7.
  • Kent ME, Romanelli F. Reexamining syphilis: An update on epidemiology, clinical manifestations, and management. Ann Pharmacother 2008;42:226–36.
  • Goh BT. Syphilis in adults. Sex Transm Infect 2005;81:448–52.
  • French P, Gomberg M, Janier M, Schmidt B, Vader P, Young H, et al. IUSTI: 2008 European guidelines on the management of syphilis. Int J STD AIDS 2009;20:300–9.
  • Rompalo AM, Lawlor J, Seaman P, Quinn TC, Zenilman JM, Hook EW. Modification of syphilitic genital ulcer manifestations by coexistent HIV infection. Sex Transm Dis 2001;28:448–54.
  • European Union. European Centre for Disease Prevention and Control. Available from: http://ecdc.europe.eu;www.essti.org. Accessed Mar 2, 2009.
  • Plagens-Rotman K, Jarząbek-Bielecka G, Merks P, Kêdzia W, Czarnecka-Operacz M. Syphilis: Then and now. Postepy Der- matol Alergol 2021;38:550–4.
  • World Health Organization. Guidelines for the management of symptomatic sexually transmitted infections. Geneva: World Health Organization; 2021 Jun. Syphilis-2015 STD Treat- ment Guidelines; 2021. Available from: https://www.cdc.gov/ std/tg2015/syphilis.htm. Accessed Aug 3, 2022.
  • Bollemeijer JG, Wieringa WG, Missotten TO, Meenken I, Loon NH, Rothova A, et al. Clinical manifestations and outcome of syphilitic uveitis. Invest Ophthalmol Vis Sci 2016;57:404–11.
  • Oliver GF, Stathis RM, Furtado JM, Arantes TE, McCluskey PJ, Matthews JM, et al. Current ophthalmology practice patterns for syphilitic uveitis. Br J Ophthalmol 2019;103:1645–9.
  • Yalçındağ FN, Özdal PC, Özyazgan Y, Batıoğlu F, Tugal-Tutkun I, BUST Study Group. Demographic and clinical characteristics of uveitis in Turkey: The first national registry report. Ocul Im- munol Inflamm 2018;26:17–26.
  • Eandi CM, Neri P, Adelman RA, Yannuzzi LA, Cunningham ET Jr., International Syphilis Study Group. Acute syphilitic posteri- or placoid chorioretinitis: Report of a case series and compre- hensive review of the literature. Retina 2012;32:1915–41.
  • Standardization of Uveitis Nomenclature (SUN) Working Group. Classification criteria for syphilitic uveitis. Am J Ophthalmol 2021;228:182–91.
  • Davis JL. Ocular syphilis. Curr Opin Ophthalmol 2014;25:513–8
  • Pichi F, Neri P. Multimodal imaging patterns of posterior syph- ilitic uveitis: A review of the literature, laboratory evaluation and treatment. Int Ophthalmol 2020;40:1319–29.
  • Fu EX, Geraets RL, Dodds EM, Echandi LV, Colombero D, Mc- Donald, et al. Superficial retinal precipitates in patients with syphilitic retinitis. Retina 2010;30:1135–43.
  • Pichi F, Curi AL, Vasconcelos-Santos DV, Marchese A, Cicinelli MV, Miserocchi E, et al. Optical coherence tomography find- ings in infectious posterior uveitis. Ocul Immunol Inflamm 2022;30:1–12.
  • Wickremasinghe S, Ling C, Stawell R, Yeoh J, Hall A, Zamir E. Syphilitic punctate inner retinitis in immunocompetent gay men. Ophthalmology 2009;116:1195–200.
  • Reddy S, Cunningham ET Jr., Spaide RF. Syphilitic retinitis with focal inflammatory accumulations. Ophthalmic Surg Laser Imaging 2006;37:429–31.
  • Schlaen A, Aquino MP, Ormaechea MS, Couto C, Saravia M. Spectral optical coherence tomography findings in an adult patient with syphilitic bilateral posterior uveitis and uni- lateral punctate inner retinitis. Am J Ophthalmol Case Rep 2019;15:100489.
  • de Souza EC, Jalkh AE, Trempe CL, Cunha S, Schepens CL. Un- usual central chorioretinitis as the first manifestation of early secondary syphilis. Am J Ophthalmol 1988;105:271–6.
  • Gass JD, Braunstein RA, Chenoweth RG. Acute syphilitic poste- rior placoid chorioretinitis. Ophthalmology 1990;97:1288–97.
  • Cunningham ET Jr., Eandi CM, Pichi F. Syphilitic uveitis. Ocul Immunol Inflamm 2014;22:2–3.
  • Pichi F, Ciardella AP, Cunningham ET Jr., Morara M, Veronese C, Jumper JM, et al. Spectral domain optical coherence tomog- raphy findings in patients with acute syphilitic posterior pla- coid chorioretinopathy. Retina 2014;34:373–84.
  • Brito P, Penas S, Carneiro A, Palmares J, Reis FF. Spectral-domain optical coherence tomography features of acute syphilitic pos- terior placoid chorioretinitis: The role of autoimmune response in pathogenesis. Case Rep Ophthalmol 2011;2:39–44.
  • Amaratunge BC, Camuglia JE, Hall AJ. Syphilitic uveitis: A re- view of clinical manifestations and treatment outcomes of syphilitic uveitis in human immunodeficiency virüs positive and negative patients. Clin Exp Ophthalmol 2010;38:68–74.
  • Mendelsohn AD, Jampol LM. Syphilitic retinitis. A cause of necrotizing retinitis. Retina 1984;4:221–4.
  • Díaz-Valle D, Allen DP, Sánchez AA, Aguado CB, Castillo, JM, Aceñero MJ. Simultaneous bilateral exudative retinal detach- ment and peripheral necrotizing retinitis as presenting manifestations of concurrent HIV and syphilis infection. Ocul Immunol Inflamm 2005;13:459–62.
  • Zambon F, Silva FL, de Sa Cavalcante AF, Nakashima Y, Helal J. Syphilitic retinitis and panuveitis simulating acute retinal necrosis: Case report. Arq Bras Oftalmol 2010;73:288–290.
  • Majumder PD, Chen EJ, Shah J, Ho DC, Biswas J, Yin LS, et al. Ocular syphilis: An update. Ocul Immunol Inflamm 2019;27:117–25.
  • Lobes LA, Folk JC. Syphilitic phlebitis simulating branch vein occlusion. Ann Ophthalmol 1981;13:825–7.
  • Anderson AM, Bergstrom CS. Syphilitic frosted branch angiitis with anterior uveitis in a patient with a new HIV diagnosis. Lancet Infect Dis 2009;9:453.
  • Jumper JM, Machemer R, Gallemore RP, Jaffe GJ. Exudative retinal detachment and retinitis associated with acquired syphilitic uveitis. Retina 2000;20:190–4.
  • Lin YC, Lo KJ, Chen SJ, Hwang DK. Ocular syphilis mimicking Vogt-Koyanagi-Harada disease. Taiwan J Ophthalmol 2019;9:271–5.
  • Huang CY, Kang EY, Chen KJ, Wang NK. Acute syphilitic posterior placoid chorioretinopathy mimicking central serous chorioretinopathy: A case report. Taiwan J Ophthalmol 2018;8:176–8.
  • Kim JA, Park KH, Woo SJ. A case of syphilitic outer retinitis mimicking acute zonal occult outer retinopathy. Korean J Ophthalmol 2014;28:497–9.
  • Lima BR, Mandelcorn ED, Bakshi N, Nussenblatt RB, Sen HN. Syphilitic outer retinopathy. Ocul Immunol Inflamm 2014;22:4–8.
  • Saleh MG, Campbell JP, Yang P, Lin P. Ultra-wide-field fundus autofluorescence and spectral-domain optical coherence tomography findings in syphilitic outer retinitis. Ophthalmic Surg Lasers Imaging Retina 2017;48:208–15.
  • Hussnain SA, Daccache A, Klausner JD, Yannuzzi L, Gal-Or O. Multimodal imaging of atypical acute syphilitic posterior pla- coid chorioretinitis mimicking a white dot syndrome. Oph- thalmic Surg Lasers Imaging Retina 2019;50:e52–5.
  • Russell JF, Pichi F, Scott NL, Hartley MJ, Bell D, Agarwal A, et al. Masqueraders of multiple evanescent white dot syndrome (MEWDS). Int Ophthalmol 2020;40:627–38.
  • Zhang T, Zhu Y, Xu G. Clinical features and treatments of syphilitic uveitis: A systematic review and meta-analysis. J Ophthalmol 2017;2017:6594849.
  • Klein A, Fischer N, Goldstein M, Shulman S, Habot-Wilner Z. The great imitator on the rise: Ocular and optic nerve manifes- tations in patients with newly diagnosed syphilis. Acta Oph- thalmol 2019;97:e641–7.
  • Akpek EK, Thorne JE, Qazi FA, Do DV, Jabs DA. Evaluation of patients with scleritis for systemic disease. Ophthalmology 2004;111:501–6.
  • Murthy SI, Sabhapandit S, Balamurugan S, Subramaniam P, Sainz-de-la-Maza M, Agarwal M, et al. Scleritis: Differentiating infectious from non-infectious entities. Indian J Ophthalmol 2020;68:1818–28.
  • Fénolland JR, Bonnel S, Rambaud C, Froussart-Maille F, Ri- gal-Sastourné JC. Syphilitic scleritis. Ocul Immunol Inflamm 2016;24:93–5.
  • Yoon KC, Im SK, Seo MS, Park YG. Neurosyphilitic episcleritis. Acta Ophthalmol Scand 2005;83:265–6.
  • Orsoni JG, Zavota L, Manzotti F, Gonzales S. Syphilitic interstitial keratitis: Treatment with immunosuppressive drug combination therapy. Cornea 2004;23:530–2.
  • Martin J, Kopplin L, Costakos D. Syphilitic interstitial keratitis treated with topical tacrolimus. Am J Ophthalmol Case Rep 202;23:101175.
  • Moradi A, Salek S, Daniel E, Gangaputra S, Ostheimer TA, Burkholder BM, et al. Clinical features and incidence rates of ocular complications in patients with ocular syphilis. Am J Ophthalmol 2015;159:334–43.
  • Sudharshan S, Menia NK, Selvamuthu P, Tyagi M, Kumarasamy N, Biswas J. Ocular syphilis in patients with human immunod- eficiency virus/acquired immunodeficiency syndrome in the era of highly active antiretroviral therapy. Indian J Ophthal- mol 2020;68:1887–93.
  • Luo Y, Xie Y, Xiao Y. Laboratory diagnostic tools for syphilis: Current status and future prospects. Front Cell Infect Microbiol 2021;10:574806.
  • Rathinam SR, Tugal-Tutkun I, Agarwal M, Rajesh V, Egriparmak M, Patnaik G. Immunological tests and their interpretation in uveitis. Indian J Ophthalmol 2020;68:1737–48.
  • Tsang RS, Morshed M, Chernesky MA, Jayaraman GC, Kad- khoda K. Canadian public health laboratory network labora- tory guidelines for the use of direct tests to detect syphilis in Canada. Can J Infect Dis Med Microbiol 2015;26:13A–7.
  • Troutbeck R, Chhabra R, Jones NP. Polymerase chain reaction testing of vitreous in atypical ocular syphilis. Ocul Immunol Inflamm 2013;21:227–30.
  • Ratnam S. The laboratory diagnosis of syphilis. Can J Infect Dis Med Microbiol 2005;16:45–51.
  • Centers for Disease Control and Prevention. Syphilis testing algorithms using treponemal tests for initial screening--four laboratories, New York City, 2005-2006. MMWR Morb Mortal Wkly Rep 2008;57:872–5.
  • Centers for Disease Control and Prevention. Sexually Transmit- ted Diseases (STDs): 2021 STI Treatment Guidelines-Syphilis: Updated Diagnostic, Treatment, and Screening Recommen- dations for STIs. Available from: https://www.cdc.gov/std/ treatment-guidelines/syphilis.htm. Accessed Jul 22, 2021.
  • Tong ML, Lin LR, Liu LL, Zhang HL, Yang TC, Chen YY, et al. Analysis of 3 algorithms for syphilis serodiagnosis and implications for clinical management. Clin Infect Dis 2014;58:1116–24.
  • Nair N, Sudharshan S, Anand AR, Biswas J, Therese KL. Utility of treponemal testing from aqueous fluid in the diagnosis of oc- ular syphilis in patients with HIV/AIDS. Ocul Immunol Inflamm 2022;30:444–50.
  • Silpa-Archa S, Preble JM, Foster CS. Vitreous treponemal antibody as a supplementary test to serology for the confirmation of syphilitic chorioretinitis. Retin Cases Brief Rep 2020;14:166–9.
  • Silpa-Archa S, Hoopholerb T, Foster CS. Appraisal of vitreous syphilis antibody as a novel biomarker for the diagnosis of syphilitic uveitis: A prospective case-control study. Eye (Lond). 2022 Jan 16. doi: 10.1038/s41433-021-01902-6. [Epub ahead of print].
  • Clement ME, Okeke NL, Hicks CB. Treatment of syphilis: A sys- tematic review. JAMA 2014;312:1905–17.
  • Janier M, Unemo M, Dupin N, Tiplica GS, Potočnik M, Patel R. 2020 European guideline on the management of syphilis. J Eur Acad Dermatol Venereol 2021;35:574–88.
  • Amode R, Makhloufi S, Calin R, Caumes E. Oral doxycycline for syphilitic uveitis: A case report highlighting potential efficacy. J Antimicrob Chemother 2018;73:1999–2000.
  • Majumder PD, Mayilvakanam L, Palker AH, Sridharan S, Biswas J. Intravitreal sustained-release dexamethasone implant for the treatment of persistent cystoid macular edema in ocula syphilis. Indian J Ophthalmol 2019;67:1487–90.
  • Lautredou CC, Hardin JS, Chancellor JR, Uwaydat SH, Ellabban AA, Sallam AB. Repeat intravitreal dexamethasone implant forrefractory cystoid macular edema in syphilitic uveitis. Case Rep Ophthalmol Med 2018;2018:7419823.
  • Solebo AL, Westcott M. Corticosteroids in ocular syphilis. Ophthalmology 2007;114:1593.
  • Sahin O, Ziaei A. Clinical and laboratory characteristics of ocular syphilis, cinfection, and therapy response. Clin Ophthalmol 2015;10:13–28.
  • Sahin O, Ziaei A. The role of methotrexate in resolving ocular inflammation after specific therapy for presumed latent syphilitic uveitis and presumed tuberculosis-related uveitis. Retina 2014;34:1451–9.
APA ozdemir yalcinsoy k, OZDAL P (2022). Ocular syphilis. , 36 - 46. 10.14744/eer.2022.57966
Chicago ozdemir yalcinsoy kubra,OZDAL PINAR CAKAR Ocular syphilis. (2022): 36 - 46. 10.14744/eer.2022.57966
MLA ozdemir yalcinsoy kubra,OZDAL PINAR CAKAR Ocular syphilis. , 2022, ss.36 - 46. 10.14744/eer.2022.57966
AMA ozdemir yalcinsoy k,OZDAL P Ocular syphilis. . 2022; 36 - 46. 10.14744/eer.2022.57966
Vancouver ozdemir yalcinsoy k,OZDAL P Ocular syphilis. . 2022; 36 - 46. 10.14744/eer.2022.57966
IEEE ozdemir yalcinsoy k,OZDAL P "Ocular syphilis." , ss.36 - 46, 2022. 10.14744/eer.2022.57966
ISNAD ozdemir yalcinsoy, kubra - OZDAL, PINAR CAKAR. "Ocular syphilis". (2022), 36-46. https://doi.org/10.14744/eer.2022.57966
APA ozdemir yalcinsoy k, OZDAL P (2022). Ocular syphilis. European eye research, 2(3), 36 - 46. 10.14744/eer.2022.57966
Chicago ozdemir yalcinsoy kubra,OZDAL PINAR CAKAR Ocular syphilis. European eye research 2, no.3 (2022): 36 - 46. 10.14744/eer.2022.57966
MLA ozdemir yalcinsoy kubra,OZDAL PINAR CAKAR Ocular syphilis. European eye research, vol.2, no.3, 2022, ss.36 - 46. 10.14744/eer.2022.57966
AMA ozdemir yalcinsoy k,OZDAL P Ocular syphilis. European eye research. 2022; 2(3): 36 - 46. 10.14744/eer.2022.57966
Vancouver ozdemir yalcinsoy k,OZDAL P Ocular syphilis. European eye research. 2022; 2(3): 36 - 46. 10.14744/eer.2022.57966
IEEE ozdemir yalcinsoy k,OZDAL P "Ocular syphilis." European eye research, 2, ss.36 - 46, 2022. 10.14744/eer.2022.57966
ISNAD ozdemir yalcinsoy, kubra - OZDAL, PINAR CAKAR. "Ocular syphilis". European eye research 2/3 (2022), 36-46. https://doi.org/10.14744/eer.2022.57966